Karatasakis Aris, Danek Barbara A, Karmpaliotis Dimitri, Alaswad Khaldoon, Jaffer Farouc A, Yeh Robert W, Patel Mitul, Bahadorani John N, Lombardi William L, Wyman R Michael, Grantham J Aaron, Kandzari David E, Lembo Nicholas J, Doing Anthony H, Toma Catalin, Moses Jeffrey W, Kirtane Ajay J, Parikh Manish A, Ali Ziad A, Garcia Santiago, Kalsaria Pratik, Karacsonyi Judit, Alame Aya J, Thompson Craig A, Banerjee Subhash, Brilakis Emmanouil S
VA North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, TX, United States.
Columbia University, New York, NY, United States.
Int J Cardiol. 2016 Dec 1;224:50-56. doi: 10.1016/j.ijcard.2016.08.317. Epub 2016 Aug 23.
Various scoring systems have been developed to predict the technical outcome and procedural efficiency of chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
We examined the predictive capacity of 3 CTO PCI scores (Clinical and Lesion-related [CL], Multicenter CTO registry in Japan [J-CTO] and Prospective Global Registry for the Study of Chronic Total Occlusion Intervention [PROGRESS CTO] scores) in 664 CTO PCIs performed between 2012 and 2016 at 13 US centers.
Technical success was 88% and the retrograde approach was utilized in 41%. Mean CL, J-CTO and PROGRESS CTO scores were 3.9±1.9, 2.6±1.2 and 1.4±1.0, respectively. All scores were inversely associated with technical success (p<0.001 for all) and had moderate discriminatory capacity (area under the curve 0.691 for the CL score, 0.682 for the J-CTO score and 0.647 for the PROGRESS CTO score [p=non-significant for pairwise comparisons]). The difference in technical success between the minimum and maximum CL score strata was the highest (32%, vs. 15% for J-CTO and 18% for PROGRESS CTO scores). All scores tended to perform better in antegrade-only procedures and correlated significantly with procedure time and fluoroscopy dose; the CL score also correlated significantly with contrast utilization.
CL, J-CTO and PROGRESS CTO scores perform moderately in predicting technical outcome of CTO PCI, with better performance for antegrade-only procedures. All scores correlate with procedure time and fluoroscopy dose, and the CL score also correlates with contrast utilization.
已开发出多种评分系统来预测慢性完全闭塞(CTO)经皮冠状动脉介入治疗(PCI)的技术结果和手术效率。
我们在2012年至2016年间于美国13个中心进行的664例CTO PCI手术中,检验了3种CTO PCI评分(临床和病变相关[CL]、日本多中心CTO注册研究[J-CTO]和慢性完全闭塞介入治疗前瞻性全球注册研究[PROGRESS CTO]评分)的预测能力。
技术成功率为88%,41%的手术采用了逆向技术。CL、J-CTO和PROGRESS CTO评分的均值分别为3.9±1.9、2.6±1.2和1.4±1.0。所有评分均与技术成功率呈负相关(所有p<0.001),且具有中等的鉴别能力(CL评分的曲线下面积为0.691,J-CTO评分为0.682,PROGRESS CTO评分为0.647[两两比较p=无显著性差异])。CL评分最低和最高分层之间的技术成功率差异最大(32%,而J-CTO为15%,PROGRESS CTO为18%)。所有评分在仅采用正向技术的手术中往往表现更好,且与手术时间和透视剂量显著相关;CL评分也与造影剂用量显著相关。
CL、J-CTO和PROGRESS CTO评分在预测CTO PCI的技术结果方面表现中等,在仅采用正向技术的手术中表现更佳。所有评分均与手术时间和透视剂量相关,CL评分还与造影剂用量相关。